111 results
10-K
2023 FY
EX-10.64
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
10-K
2023 FY
EX-10.55
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
10-K
2023 FY
EX-10.60
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
10-K
2023 FY
EX-10.66
NRXP
NRX Pharmaceuticals Inc
Annual report
29 Mar 24
5:18pm
8-K
EX-10.1
NRXP
NRX Pharmaceuticals Inc
14 Feb 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
ug0t46
29 Dec 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
knvgqt
14 Sep 23
NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support
4:04pm
8-K
EX-10.1
zand 36alnc5r
1 Sep 23
NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 per share
4:48pm
8-K
EX-10.1
nk467
28 Jul 23
Entry into a Material Definitive Agreement
5:15pm
8-K/A
EX-10.1
v64d2ro
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K/A
EX-10.2
ixgomlg z27n
7 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
5:18pm
8-K
EX-10.1
rhfdmli4
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K
EX-10.2
zjg0n 90tmqoz
6 Jun 23
NRx Pharmaceuticals Announces $6.28 Million Registered Direct Offering
4:27pm
8-K
EX-10.1
e5pb9g q44
5 Jun 23
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
8:00am